Sabra Health Care REIT, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $774.6M | $703.2M | $647.5M | $624.8M | $569.5M |
| Pretax income | $153.4M | $128.1M | $18.7M | $21.7M | $80.7M |
| Income tax expense | $1.8M | $1.0M | $2.0M | $1.2M | $1.8M |
| Net income | $155.6M | $126.7M | $13.8M | -$77.6M | -$113.3M |
| Balance Sheet | |||||
| Cash and equivalents | $71.5M | $60.5M | $41.3M | $49.3M | $112.0M |
| Total assets | $5.5B | $5.3B | $5.4B | $5.7B | $6.0B |
| Total liabilities | $2.7B | $2.6B | $2.6B | $2.7B | $2.6B |
| Total debt | $2.6B | $2.4B | $2.4B | $2.5B | $2.4B |
| Stockholders' equity | $2.8B | $2.7B | $2.8B | $3.1B | $3.4B |
| Cash Flow Statement | |||||
| Cash from operations | $348.6M | $310.5M | $300.6M | $315.7M | $356.4M |
| Depreciation and amortization | $187.0M | $169.6M | $183.1M | $187.8M | $179.0M |
| Stock-based compensation | $11.4M | $9.0M | $7.9M | $7.5M | $7.9M |
| Capital expenditure | $41.5M | $54.7M | $84.9M | $54.5M | $42.7M |
| Free cash flow | $307.1M | $255.8M | $215.7M | $261.3M | $313.7M |
| Dividends paid | $289.5M | $280.1M | $277.4M | $277.2M | $262.9M |
Shares outstanding 252.2M · Free float 98.6%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.